Sab Inhibitors

SAB inhibitors, or Serine/Arginine-Rich Splicing Factor inhibitors, represent a class of small molecules designed to target a specific set of proteins involved in the complex process of mRNA splicing. mRNA splicing is a fundamental step in gene expression, where non-coding regions (introns) are removed, and coding regions (exons) are joined together to form mature mRNA molecules. This process is essential for the proper functioning of genes and the production of functional proteins. The SAB proteins, also known as splicing factors, play a pivotal role in orchestrating this splicing process by assisting in the formation and activation of the spliceosome, a large and dynamic molecular complex responsible for precise splicing events.SAB inhibitors work by disrupting the function of SAB proteins within the spliceosome machinery. They achieve this by binding to specific components of the spliceosome, such as the SF3B complex, which is a crucial player in spliceosome assembly and activation. By binding to SF3B or other SAB-related proteins, these inhibitors interfere with the spliceosome's ability to recognize and process pre-mRNA substrates accurately.

This interference leads to errors in mRNA splicing, including the retention of intronic sequences in the mature mRNA, which can result in the generation of non-functional or potentially harmful protein products. Essentially, SAB inhibitors create a molecular roadblock within the splicing process, preventing the formation of functional spliceosomal complexes and causing the accumulation of aberrant RNA species. This accumulation of faulty mRNA molecules can have detrimental effects on cellular processes and is particularly relevant in the context of certain diseases, such as cancer, where splicing defects are commonly observed. Therefore, the development and study of SAB inhibitors have provided valuable insights into the intricate mechanisms of mRNA splicing, highlighting their importance in basic molecular biology research and potential implications for the understanding of disease mechanisms.